Global eye care is a US$20–24B market — yet 80% of new brands stall at the supply chain: no formula, no filing, no capacity, cross-border pitfalls. Your hero product shouldn't die in the factory. EYEOEM's 20+ years turn it into one-stop delivery from 0 to 1 — you sell, we run the supply chain.
Four A-grade signals prove "eye" is moving from supporting act to skincare's innovation front line — and supply chain is the gate most brands can't pass.
The four poles (N.America / Europe / APAC) are stable; real growth is in SEA, Middle East, LatAm — and only compliance-first supply chains capture it. The format shift (mask innovation, serum growth) is the global through-line.
High compliance bar under FDA; TikTok US K-Beauty +132% drives cross-border eye care (EYEOEM).
Strict anti-aging rules, retinol capped (0.3% RE); recyclable packaging standard.
Mature premium anti-aging; high acceptance of PDRN / peptides at home.
Olive Young as export hub; freeze-dried / patch innovation leads.
Aesthetic efficacy surging; Indonesia halal compliance is the gate (public data).
E-com / duty-free upside; open to China supply chain.
APAC leads (32–41%), NA/EU follow. Source: multi-firm mid-points
No high-authority single figure; range only: GVR 2024 / R&M 2025 / GGI 2025 (C, reference). Wide caliber w/ serum & mask ≈ US$20–24B.
Online 3-category GMV ¥15.4B; masks the only decline, yet AUP rises (volume down, price up).
Douyin > half, content-commerce led. Source: EYEOEM
Local ¥100–200, int'l >¥500 (68%); ¥200–400 is no-man's land
Net +¥490M: Tmall +309 / JD +204 / Douyin −23. Douyin flat, Tmall/JD take new demand. Source: DataStory
>¥439 is 11.1% volume but 54.7% value — the tip eats profit. Source: Shangpu
Supply chain is ours, brand slot is empty — the steepest growth curve.
7 of top-10 skincare are Korean; K-Beauty +132% vs platform +120%. Source: EYEOEM
$50–100 only 4% density — soluble-microneedle/freeze-dried premium blue ocean
22 rivals, 3 open slots: leaders hold share but haven't locked it; format innovation overtakes in a year.
International duopoly >¥500; local fights ¥100–400. Source: DataStory / EYEOEM (Tmall/Chanmama)
$50–100 / ¥300–500, only 4% Amazon density. Soluble/freeze-dried microneedles are the only lever.
Blue oceanBuzz +1243%, no #1 product. Ectoin/copper peptide = natural carrier & blue visual asset.
Empty mindshareUS shifted to "prep base"; mainstream still writes night. Reframe masks/serums to instant-smooth.
Occasion gapIngredient heat matrix + 2026 compliance timeline (red lines).
PDRN / recombinant collagen / freeze-dry on top; exosomes banned. Source: EYEOEM
China · NMPA Notice 70 (2026-07)
Except whitening/sunscreen/anti-hair-loss, methods flexible; similar formulas may share efficacy data, some animal tests waived — cuts multi-SKU filing cost, clear win for indie & OEM/ODM.
China · efficacy (3-choose-1, not mandatory trial)
Anti-wrinkle/firming = human / consumer / lab test (pick one); only whitening/sunscreen/anti-hair-loss need mandatory human trial.
EU · allergen labeling 2026-07-31 (enforcement)
Fragrance allergens 26 → 80+; new labeling by 2026-07-31, full compliance 2028-07-31; "fragrance-free" eye claims need review.
EU · retinol cap (eye contour 0.3% RE)
Reg (EU) 2024/996 caps leave-on face & eye contour at 0.3% RE; full delisting window 2026–2027.
EU 2026/10/10 · PFAS limit
PFHxA >25ppb banned; design low-PFAS, fragrance-free.
Indonesia · Halal by 2026/10/17
SEA export needs early halal prep, 8–12 wk review window.
Younger + lower-tier confirmed; preventive care and sensitive skin are growth engines.
Mixed metrics for priority setting. Source: EYEOEM
From seller.eyeoem.com/factory.html: 20+ yrs, 5000+ brand clients, 20,000+ formulas, 12 automated lines — the trust base for R&D-to-production.
20,000㎡ 数字智造园 · 10 万级 GMPC 车间 · 德国 IKA 均质 + 智能乳化 · 单日灌装 10W+
Expert-led R&D on Eastern skin; freeze-dry/microneedle/collagen innovation
100+ 顶尖原料商 · 源头直采核心活性成分 · 全品类包材生态矩阵
Beyond OEM: insight → hero product → marketing, end-to-end
Traditional eye masks are under pressure; freeze-dried masks and soluble microneedles are the format frontier — the core entry point for premium tech positioning.
TikTok US K-Beauty +132%; supply chain is ours, brand slot empty — export second curve.
Buzz +1243% with no #1; ectoin/copper peptide = natural carrier & blue visual asset.
US shifted to "prep base"; reframe masks/serums as "10-min instant smooth".
Int'l locks >¥500 (68%), local holds ¥100–200; the middle is no-man's land — bundle value can claim it.
| Opportunity | EyeOEM competency | Action |
|---|---|---|
| FD / microneedle | R&D engine + intelligent mfg | FD line + microneedle tooling, 12 lines flex |
| Cross-border K-Beauty | Full-link empower + global supply | CPNP/FDA pack + sachets + TikTok kit |
| Sensitive × eye | R&D engine + global supply | Ectoin/Cu-peptide fragrance-free, 100+ sourcing |
| Makeup-prep | Full-link empower | Instant-smooth claims + gift kit plan |
| ¥200–400 gap | Intelligent mfg + full-link | High-value kit (mask+ampoule), bare cost ≤10% |
Sources: EYEOEM "2026 Eye-Care Dossier" + seller.eyeoem.com/factory.html; figures are strategic reference, not audited.
One-stop OEM/ODM/OBM empowerment proposals and executable plans for Perfect, Marubi, PROYA, Perfect Diary & international leaders: insight → formula → compliance → delivery.
① Pain Direct-selling skincare brand with weak eye-care equity and no hero SKU; nearly absent from the high-potential ¥200–400 band (Lancôme/Estée Lauder lock ≥¥500).
② EYEOEM solution 20,000+ formulas + full dosage forms build a "peptide-collagen mask + serum" kit for member repurchase; GMPC/ISO22716 and medical-grade compliance ensure trust; reuses the validated Ouzhilin kit model (¥10.59M / 77K units / 30 days).
③ Value A professional kit closes the eye-care equity gap and drives repurchase & member loyalty via the direct channel.
① Pain Domestic eye-mask leader (Red Butterfly ¥960M, #1 domestic) with strong peptide equity, but weak overseas and no cross-border foothold.
② EYEOEM solution Full-chain enablement + CPNP/FDA upgrade the "peptide butterfly mask" to a cross-border freeze-dried version for EU/US & TikTok Shop; 12 lines + global sourcing control cost; sachets beat BIODANCE's jar.
③ Value Bolsters peptide equity while opening a cross-border second curve.
① Pain Dual-Anti eye cream 3.0 (¥234–599, Tmall #5) rides an ingredient story but eye care isn't core; open band lacks a monopoly hero.
② EYEOEM solution R&D + 20,000㎡ park capacity build a "dual-anti + collagen-peptide" hero cream/mask dual format to consolidate ¥200–400; GMPC/ISO22716/FDA back claims; insight + kits make eye care a hero range.
③ Value Elevates eye care to a core line with a monopoly-level hero in the open band.
① Pain Makeup gene and young fit, but a weak eye line with no hero SKU; absent from the ¥960M mask & young portable market.
② EYEOEM solution Freeze-dried/microneedle + youthful library craft a "portable mask + serum pen" echoing kazoo and other leading freeze-dried plays; CPNP/FDA + sourcing deliver value; OBM social kits leverage makeup traffic.
③ Value A youth hero closes the eye-care gap and scales fast via makeup traffic.
① Pain Collagen patches ($23/60) lead TikTok Shop (#1, 365K+ units) but jar is non-portable, only 869 reviews, pricing power unrealized; needs China entry & upgrade.
② EYEOEM solution Freeze-dried + collagen/peptide + CPNP/NMPA build a "sachet portable + upgraded formula" China edition; 20,000+ library upgrades actives (vs Grace&Stella's stale formula); cross-border enablement lands China e-com; OBM localization.
③ Value Portable upgrade + local compliance open China and unlock pricing power.
| Brand | Core pain | EYEOEM solution | Target band / format |
|---|---|---|---|
| 完美 Perfect China | Weak eye equity, no hero | Peptide-collagen kit, device-grade | ¥200–400 / kit |
| 丸美 Marubi | Weak overseas | Cross-border freeze-dried, CPNP/FDA, sachets | ¥148–368 / FD mask |
| 珀莱雅 PROYA | Eye line not core | Dual-anti+collagen dual format, GMPC/FDA | ¥200–400 / cream+mask |
| 完美日记 Perfect Diary | Weak eye line | Portable FD+pen, OBM social | ¥99–199 / FD+pen |
| BIODANCE | Jar pain, no premium | China sachet edition, CPNP/NMPA | $17–23 / FD patch |
① Contact the EYEOEM team for one-stop eye-care OEM/ODM incubation and go live within 1–2 months; ② prep international export certificates / EU PFAS / Indonesia halal 6–12 weeks ahead.
① 20,000+ formula library is already organized into eye-care hero modules (PDRN, collagen, freeze-dry, microneedle) for white-label, customization, or re-R&D ② GMPC+ISO22716+FDA+CPNP compliance packs for export-bound brands; ③ 12 fully automated modern lines for flexible production — partners are welcome to visit and audit the factory. ④ Full-link brand empowerment takes you from OEM to co-incubation for end-to-end brand solutions.
Drop your needs — the EYEOEM team returns a tailored supply-chain plan & quote within 24h, or reach us directly below.
20+ yrs · 5,000+ clients · 20,000+ formulas · 12 lines · GMPC+ISO22716+FDA+CPNP+SGS, one compliance pass.